John Demaree

Chief Commercial Officer, G1 Therapeutics, Inc.

Companies

Karyopharm Therapeutics Inc.Chief Commercial Officer Mar 17, 2020 to Mar 1, 2021¹
G1 Therapeutics, Inc.Chief Commercial Officer Jul 6, 2018 to Feb 7, 2020²

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARKaryopharm Therapeutics Inc., Chief Commercial Officer
2
SEC EDGARG1 Therapeutics, Inc., Chief Commercial Officer